Kidney Health in the COVID-19 Pandemic: An Umbrella Review of Meta-analyses and Systematic Reviews

Overview

Journal Front Public Health

Specialty Public Health

Date 2022 Sep 29

PMID 36172213

Authors

Letian Yang

Jian Li

Wei Wei

Cheng Yi

Yajun Pu

Ling Zhang

Tianlei Cui

Liang Ma

Juqian Zhang

Jay Koyner

Yuliang Zhao

Ping Fu

Affiliations

Soon will be listed here.

Abstract

Background: This umbrella review aims to consolidate evidence from systematic reviews and meta-analyses investigating the impact of the coronavirus disease-2019 (COVID-19) on kidney health, and the associations between kidney diseases and clinical outcomes in COVID-19 patients.

Methods: Five databases, namely, EMBASE, PubMed, Web of Science, the Cochrane Database of Systematic Reviews and Ovid Medline, were searched for meta-analyses and systematic reviews from January 1, 2020 to June 2, 2022. Two reviewers independently selected reviews, identified reviews for inclusion and extracted data. Disagreements were resolved by group discussions. Two reviewers independently assessed the methodological quality of all included reviews using ROBIS tool. A narrative synthesis was conducted. The characteristics and major findings of the included reviews are presented using tables and forest plots. The included meta-analyses were updated when necessary. The review protocol was prospectively registered in PROSPERO (CRD42021266300).

Results: A total of 103 reviews were identified. Using ROBIS, 30 reviews were rated as low risk of bias. Data from these 30 reviews were included in the narrative synthesis. Ten meta-analyses were updated by incorporating 119 newly available cohort studies. Hospitalized COVID-19 patients had a notable acute kidney injury (AKI) incidence of 27.17%. AKI was significantly associated with mortality (pooled OR: 5.24) and severe conditions in COVID-19 patients (OR: 14.94). The pooled prevalence of CKD in COVID-19 patients was 5.7%. Pre-existing CKD was associated with a higher risk of death (pooled OR: 2.21) and disease severity (pooled OR: 1.87). Kidney transplant recipients were susceptible to SARS-CoV-2 infection (incidence: 23 per 10,000 person-weeks) with a pooled mortality of 18%.

Conclusion: Kidney disease such as CKD or recipients of kidney transplants were at increased risk of contracting COVID-19. Persons with COVID-19 also had a notable AKI incidence. AKI, the need for RRT, pre-existing CKD and a history of kidney transplantation are associated with adverse outcomes in COVID-19.

Systematic Review Registration: www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021266300, identifier: CRD42021266300.

Citing Articles

Tripartite motif 22 (TRIM22) downregulates TLR3-induced CCL5 expression in human renal proximal tubular epithelial cells.

Tachizaki M, Kobori Y, Kawaguchi S, Seya K, Tanaka H, Imaizumi T Mol Biol Rep. 2025; 52(1):306.

PMID: 40080304 DOI: 10.1007/s11033-025-10409-2.

Multisystem inflammatory syndrome in children: an Umbrella review.

Shioji N, Sumie M, Englesakis M, Gilfoyle E, Maynes J, Aoyama K J Anesth. 2024; 38(3):309-320.

PMID: 38530453 DOI: 10.1007/s00540-024-03323-7.

COVID-19 and Kidney: The Importance of Follow-Up and Long-Term Screening.

Rai V Life (Basel). 2023; 13(11).

PMID: 38004277 PMC: 10672056. DOI: 10.3390/life13112137.

Temporal validation of the MMCD score to predict kidney replacement therapy and in-hospital mortality in COVID-19 patients.

Ventura V, Pereira P, Pires M, Asevedo A, Jorge A, Dos Santos A BMC Nephrol. 2023; 24(1):292.

PMID: 37794354 PMC: 10552198. DOI: 10.1186/s12882-023-03341-9.

A network meta-analysis of association between cardiometabolic risk factors and COVID-19 outcome severity.

Li A, Yang B, Li Y, Huynh R, Shim S, Lo K J Diabetes. 2023; 15(11):968-977.

PMID: 37649300 PMC: 10667650. DOI: 10.1111/1753-0407.13445.

References

. Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):465-471. PMC: 7755058. DOI: 10.15585/mmwr.mm6915e4. View

Aronoff S, Hall A, Del Vecchio M . The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review. J Pediatric Infect Dis Soc. 2020; 9(6):746-751. PMC: 7797745. DOI: 10.1093/jpids/piaa112. View

Roberts G, Phillips D, McCarthy R, Bolusani H, Mizen P, Hassan M . Acute kidney injury risk assessment at the hospital front door: what is the best measure of risk?. Clin Kidney J. 2015; 8(6):673-80. PMC: 4655789. DOI: 10.1093/ckj/sfv080. View

Whiting P, Savovic J, Higgins J, Caldwell D, Reeves B, Shea B . ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2015; 69:225-34. PMC: 4687950. DOI: 10.1016/j.jclinepi.2015.06.005. View

Sullivan M, Lees J, Drake T, Docherty A, Oates G, Hardwick H . Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrol Dial Transplant. 2021; 37(2):271-284. PMC: 8788218. DOI: 10.1093/ndt/gfab303. View

Hui K, Ho J, Cheung M, Ng K, Ching R, Lai K . SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022; 603(7902):715-720. DOI: 10.1038/s41586-022-04479-6. View

Ng J, Hirsch J, Hazzan A, Wanchoo R, Shah H, Malieckal D . Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis. 2020; 77(2):204-215.e1. PMC: 7833189. DOI: 10.1053/j.ajkd.2020.09.002. View

Brienza N, Puntillo F, Romagnoli S, Tritapepe L . Acute Kidney Injury in Coronavirus Disease 2019 Infected Patients: A Meta-Analytic Study. Blood Purif. 2020; 50(1):35-41. PMC: 7445379. DOI: 10.1159/000509274. View

Zhang T, Huang W, Guan W, Hong Z, Gao J, Gao G . Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression. J Thorac Dis. 2021; 12(12):7429-7441. PMC: 7797827. DOI: 10.21037/jtd-20-1743. View

10.

Chan K, Yu K, Lee P, Lai K, Tang S . Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes. Front Med (Lausanne). 2021; 8:678200. PMC: 8185046. DOI: 10.3389/fmed.2021.678200. View

11.

Shi Q, Wang Z, Liu J, Wang X, Zhou Q, Li Q . Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2021; 41:101155. PMC: 8523335. DOI: 10.1016/j.eclinm.2021.101155. View

12.

Khusid J, Becerra A, Gallante B, Sadiq A, Atallah W, Badani K . Cancer, Mortality, and Acute Kidney Injury among Hospitalized Patients with SARS-CoV-2 Infection. Asian Pac J Cancer Prev. 2021; 22(2):517-522. PMC: 8190375. DOI: 10.31557/APJCP.2021.22.2.517. View

13.

Zhang L, Hou J, Ma F, Li J, Xue S, Xu Z . The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis. Arch Virol. 2021; 166(8):2071-2087. PMC: 8017903. DOI: 10.1007/s00705-021-05012-2. View

14.

Allard R, Leclerc P, Tremblay C, Tannenbaum T . Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010; 33(7):1491-3. PMC: 2890346. DOI: 10.2337/dc09-2215. View

15.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

16.

Mesas A, Cavero-Redondo I, Alvarez-Bueno C, Cabrera M, de Andrade S, Sequi-Dominguez I . Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One. 2020; 15(11):e0241742. PMC: 7608886. DOI: 10.1371/journal.pone.0241742. View

17.

Papadopoulos V, Koutroulos M, Zikoudi D, Bakola S, Avramidou P, Touzlatzi N . Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis. Diabetol Int. 2021; 12(4):445-459. PMC: 7985576. DOI: 10.1007/s13340-021-00502-9. View

18.

Levin A, Stevens P . Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2013; 85(1):49-61. DOI: 10.1038/ki.2013.444. View

19.

Weinhandl E, Wetmore J, Peng Y, Liu J, Gilbertson D, Johansen K . Initial Effects of COVID-19 on Patients with ESKD. J Am Soc Nephrol. 2021; 32(6):1444-1453. PMC: 8259631. DOI: 10.1681/ASN.2021010009. View

20.

Fu Y, Cheng Y, Wu Y . Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools. Virol Sin. 2020; 35(3):266-271. PMC: 7090474. DOI: 10.1007/s12250-020-00207-4. View